bupropion has been researched along with Kahler Disease in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multiple myeloma is a severe plasma dyschrasia with no known treatment or cure, even bone marrow transplantation." | 5.32 | Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma. ( Altschuler, EL; Kast, RE, 2004) |
| "Multiple myeloma is a severe plasma dyschrasia with no known treatment or cure, even bone marrow transplantation." | 1.32 | Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma. ( Altschuler, EL; Kast, RE, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kast, RE | 2 |
| Altschuler, EL | 1 |
1 review available for bupropion and Kahler Disease
| Article | Year |
|---|---|
Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion.
Topics: Bupropion; Etanercept; Humans; Immunoglobulin G; Multiple Myeloma; Receptors, Tumor Necrosis Factor; | 2005 |
1 other study available for bupropion and Kahler Disease
| Article | Year |
|---|---|
Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bupropion; Chemotherapy, Adjuvant; Dibenzothiazepine | 2004 |